Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Alpha-GPC and Huperzine A are closely matched across evidence, studies, and safety.
Verdict
Likely helps
6 of 6 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
4 of 5 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Alpha-GPC and Huperzine A have evidence — compare verdict strength side-by-side.
300-600mg daily
Morning for cognitive enhancement, 30-60 min before workout for performance
Alpha-GPC 50% powder or capsules
50-200mcg twice daily
Morning and early afternoon, Avoid evening (may cause vivid dreams)
Huperzine A capsules (standardized extract)
1-2 hours
2-4 weeks
Acute
Same day
2-4 weeks
30-60 minutes
2-4 weeks
During use
L-Alpha-Glycerylphosphorylcholine (L-α-GPC): A Comprehensive Review of Its Preparation Techniques and Versatile Biological Effects
Journal of food science (2025) · Systematic review
Due to its high choline content (41% by weight) and ability to cross the blood-brain barrier, GPC is considered one of the most utilized sources of choline.
Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
Journal of Alzheimer's disease : JAD (2023) · Meta analysis · n=1326
We found significant effects of α-GPC in combination with donepezil on cognition [4 RCTs, mean difference (MD):1.72, 95% confidence interval (CI): 0.20 to 3.25], functional outcomes [3 RCTs, MD:0.79, 95% CI: 0.34 to 1.23], and behavioral outcomes [4 RCTs; MD: -7.61, 95% CI: -10.31 to -4.91].
Revisiting choline alphoscerate profile: a new, perspective, role in dementia?
The International journal of neuroscience (2013) · Systematic review
Choline alphoscerate (alpha-glyceryl-phosphorylcholine, alpha-GPC) is a semisynthetic derivative of phosphatidylcholine with central parasympathomimetic action.
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Traditional Chinese herbal medicine for vascular dementia
The Cochrane database of systematic reviews (2018) · Systematic review · n=3581
Two TCHMs (NaoMaiTai and TongXinLuo) had a 5% or more increased risk of AEs compared to the 'no Treatment' control, but the quality of this evidence was poor.
Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews
BMJ open (2016) · Systematic review · n=289
The quality of the reviews varied; however most (65%) scored 8/11 or more on the AMSTAR tool, indicating high quality.
Based on RCTs showing cognitive improvements in healthy adults and dementia patients. Effect sizes were modest and some studies used combination therapy. Higher doses associated with increased headache risk.
Based on meta-analysis showing MMSE improvement (WMD: 2.27) in dementia populations. Evidence primarily from dementia patients, limited data in healthy individuals. Quality concerns noted in systematic reviews regarding study methodology.
AI-estimated from published studies. Interpret as directional guidance.
Both Alpha-GPC and Huperzine A are closely matched — the best choice depends on your specific health goals.
Both Alpha-GPC and Huperzine A score equally (80) for sharpen focus.
No known interactions between Alpha-GPC and Huperzine A have been documented in our database. However, always consult a healthcare provider before combining supplements.